ADA 2025 20 - 23 June 2025

Changes in Clinical Measures among US Adults with Type 2 Diabetes and Chronic Kidney Disease Receiving Once-Weekly Semaglutide vs. Oral Antidiabetic Medications

Authors :

James Amamoo¹; Yan Wang²; Hongjiao Liu²; Manasvi Sundar²; Yan Song³; Lin Xie¹; Sherif Mehanna¹; Josh Noone¹; Caroline Swift¹; Matthew Weir⁴

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Diabetes

Chronic Kidney Disease

Congress poster

GLP-1 RA

Semaglutide

RWE HEOR

Are you a healthcare professional?